PP_1170x120_10-25-21

quadrivalent influenza vaccines

GSK ships 2018-2019 seasonal influenza vaccines for U.S. market

GSK ships 2018-2019 seasonal influenza vaccines for U.S. market

PHILADELPHIA — GlaxoSmithKline (GSK) today announced it will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2018-19 flu season, immediately following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. The U.S. Centers for Disease Control and Prevention (CDC) estimates that

Adheris Health